Horizon Pharma (NASDAQ: HZNP) is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases.
| Headquarters | Dublin, Ireland |
| Website | www.horizontherapeutics.com |
| @HZNPplc | |
| Products | ACTIMMUNE®, DUEXIS®, PENNSAID®, RAYOS®, VIMOVO® |